Nitric oxide attenuates endothelin-1-induced vasoconstriction in canine stomach

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 271, Issue 1 34-1, 1996, Pages

  Wood, J G ^a   Zhang, Q ^a   Yan, Z Y ^a   Cheung, L Y ^a,b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

ischemia reperfusion; N(G) nitro L arginine methyl ester; nitric oxide donor; vascular reactivity

Indexed keywords

ARGININE; ENDOTHELIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SPERMINE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOG; ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; STOMACH; STOMACH BLOOD FLOW; VASOCONSTRICTION;

EID: 0029756655     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1996.271.1.g27     Document Type: Article

References (33)

1. Andrews, F. J., C. Malcontenti-Wilson, and P. E. O'Brien. Protection against gastric ischemia-reperfusion injury by nitric oxide generators. Dig. Dis. Sci. 39: 366-373, 1994.
2. Bautista, P. B., and J. J. Spitzer. Inhibition of nitric oxide formation in vivo enhances superoxide release by the perfused liver. Am. J. Physiol. 266 (Gastrointest. Liver Physiol. 29): G783-G788, 1994.
3. Beckman, J. S., T. W. Becknmn, J. Chen, P. A. Marshall, and B. A. Freeman. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.Proc Natl. Acad. Sci. USA 87: 1620-1624, 1990.
4. Chen, R. Y. Z., G. Ross, K.-Y. Chyu, and P. H. Guth. Role of L-arginine-derived nitric oxide in cholinergic dilation of gastric arterioles. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H2110-H2116, 1993.
5. De Nucci, G., R. Thomas, P. D'Orléans-Juste, E. Antunes, C. Walder, T. D. Warner, and J. R. Vane. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA 85: 9797-9800, 1988.
6. B antagonist, BQ-788. Br. J. Pharmacol. 113: 1257-1262, 1994.
7. Fujitani, Y., Y. Ueda, T. Okada, Y. Urade, and H. Karaki. A selective agonist of endothelin type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta. J. Pharmacol. Exp. Ther. 267: 683-689, 1993.
8. Gaboury, J., R. C. Woodman, D. N. Granger, P. Reinhardt, and P. Kubes. Nitric oxide prevents leukocyte adherence: role of superoxide. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H862-H867, 1993.
9. Hirata, Y., T. Emori, S. Eguchi, K. Kanno, T. Imai, K. Ohta, and F. Marumo. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin. Invest. 91: 1367-1373, 1993.
10. Hirata, Y., H. Hayakawa, E. Suzuki, K. Kimura, K. Kikuchi, T. Nagano, M. Hirobe, and M. Omata. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension. Circulation 91: 1229-1235, 1995.
11. Kubes, P., and D. N. Granger. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H611-H615, 1992.
12. Kubes, P., M. Suzuki, and D. N. Granger. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88: 4651-4655, 1991.
13. Kurose, I., R. Wolf, D. C. Anderson, J. Paulson, M. Miyasaka, and D. N. Granger. Inhibition of nitric oxide production, mechanisms of vascular albumin leakage. Circ. Res. 73: 164-171, 1993.
14. Kurose, I., R. Wolf, M. B. Grisham, and D. N. Granger. Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ. Res. 74: 376-382, 1994.
15. Lefer, D. J., K. Nakanishi, W. E. Johnston, and J. Vinten-Johansen. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88: 2337-2350, 1993.
16. Lefer, D. J., K. Nakanishi, J. Vinten-Johansen, X.-L. Ma, and A. M. Lefer. Cardiac venous endothelial dysfunction after myocardial ischemia and reperfusion in dogs. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H850-H856, 1992.
17. Lerman, A., E. K. Sandok, F. L. Hildebrand, Jr., and J. C. Burnett, Jr. Inhibition of endothelium-derived relaxing factor enhances endothelin-mediated vasoconstriction. Circulation 85: 1894-1898, 1992.
18. Lopez-Belmonte, J., and B. J. R. Whittle. The involvement of endothelial dysfunction, nitric oxide and prostanoids in the rat gastric microcirculatory responses to endothelin-1. Br. J. Pharmacol. 112: 267-271, 1994.
19. Lopez-Behnonte, J., B. J. R. Whittle, and S. Moncada. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br. J. Pharmacol. 108: 73-78, 1993.
20. Lüscher, T. F., Z. Yang, M. Tschudi, L. von Segesser, P. Stulz, C. Boulanger, R. Siebenmann, M. Turina, and F. R. Bühler. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ. Res. 66: 1088-1094, 1990.
21. Ma, X.-L., A. S. Weyrich, D. J. Lefer, and A. M. Lefer. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ. Res. 72: 403-412, 1993.
22. Maragos, C. M., D. Morley, D. A. Wink, T. M. Dunams, J. E. Saavedra, A. Hoffman, A. E. Bove, L. Isaac, J. A. Hrabie, and L. K. Keefer. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Med. Chem. 34: 3242-3247, 1991.
23. Mittal, M. K., T. K. Gupta, F.-Y. Lee, C. C. Sieber, and R. G. Groszmann. Nitric oxide modulates hepatic vascular tone in normal rat liver. Am. J. Physiol. 267 (Gastrointest. Liver Physiol. 30): G416-G422, 1994.
24. Pique, J. M., J. V. Espluges, and B. J. R. Whittle. Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion. Gastroenterology 102: 168-174, 1992.
25. Pique, J. M., B. J. R. Whittle, and J. V. Espluges. The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur. J. Pharm. 174: 293-296, 1989.
26. Siegfried, M. R., C. Carey, X.-L. Ma, and A. M. Lefer. Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H771-H777, 1992.
27. Summers, S. T., M. J. Zinner, and J. A. Freischlag. Production of endothelium-derived relaxing factor (EDRF) is compromised after ischemia and reperfusion. Am. J. Surg. 166: 216-220, 1993.
28. Wallace, J. L., G. Cirino, G. de Nucci, W. McKnight, and W. K. MacNaughton. Endothelin has potent ulcerogenic and vasoconstrictor actions on the stomach. Am. J. Physiol. 256 (Gastrointest. Liver Physiol. 19): G661-G666, 1989.
29. Whittle, B. J. R. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance. Br. J. Pharm. 110: 3-17, 1993.
30. Whittle, B. J. R. Nitric oxide in gastrointestinal physiology and pathophysiology. In: Physiology of the Gastrointestinal Tract, edited by L. R. Johnson, D H. Alpers, J. Christensen, E. D. Jacobsen, and J. H. Walsh. New York: Raven, 1994, p. 267-294.
31. Whittle, B. J. R., J. Lopez-Belmonte, and D. D. Rees. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J. Pharmacol. 98: 646-652, 1989.
32. Wood, J. G., Z. Y. Yan, J. C. Davis, and L. Y. Cheung. Phosphoramidon attenuates big endothelin-1-induced vasoconstriction in canine stomach. Am. J. Physiol. 266 (Gastrointest. Liver Physiol. 29): G311-G317, 1994.
33. Wood, J. G., Z. Y. Yan, Q. Zhang, and L. Y. Cheung. Ischemia-reperfusion increases gastric motility and endothelin-1-induced vasoconstriction. Am. J. Physiol. 269 (Gastrointest. Liver Physiol. 32): G524-G531, 1995.